1Laitinen M, Hartikainen J, Hiltunen M O, et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty.Hum Gene Ther, 2000, 20; 11: 263--270.
2Lee L Y, Patel S R, Hackett N R, et al. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector cording for vascular endothelial growth factor 121. Ann Thorac Surg, 2000, 69: 14--24.
3Kornowski R, Leon M B, Fuchs S, et al. Electromagnetic guidance for catheter-based transendocardial injection:A platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coil Cardiol, 2000, 35: 1031--1039.
4Flugelman M Y, Rome J J, Virmani R, et al. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to pulsatile flow. Circ Res, 1992, 70: 348--354.
5Tio R A, Tkebuchava T, Scheuermann T H, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther, 1999,10:2953--2960.
6Schwarz E R, Speakman M T, Patterson M, et al.Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor(VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. JACC, 2000, 35:1323--1330.
7Shou M, Thirumurti V, Rajanayagam S, et al. Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. JACC,1997, 29: 1102--1106.
8Safi J, DiPaula A F, Riccioni T, et al. Adenovirus--mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart.Microvasc Res, 1999, 58: 238--249.
9Tanaka E, Hattan N, Ando K, et al. Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits. J Thorac Cardiovasc Surg, 2000, 120: 720--728.
10Rosengart T K, Lee L Y, Patel S R, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg, 1999,230: 466--470.
